Hayden Donald J Jr - Net Worth and Insider Trading

Hayden Donald J Jr Net Worth

The estimated net worth of Hayden Donald J Jr is at least $4 Million dollars as of 2024-11-13. Hayden Donald J Jr is the Director of Insmed Inc and owns about 62,197 shares of Insmed Inc (INSM) stock worth over $4 Million. Hayden Donald J Jr is the Director of Amicus Therapeutics Inc and owns about 5,814 shares of Amicus Therapeutics Inc (FOLD) stock worth over $60,989. Hayden Donald J Jr is also the Director of Theseus Pharmaceuticals Inc and owns about 10,000 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $40,600. Besides these, Hayden Donald J Jr also holds Regenxbio Inc (RGNX) , Vitae Pharmaceuticals Inc (VTAE) . Details can be seen in Hayden Donald J Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hayden Donald J Jr has not made any transactions after 2022-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Hayden Donald J Jr

To

Hayden Donald J Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hayden Donald J Jr owns 6 companies in total, including Regenxbio Inc (RGNX) , Insmed Inc (INSM) , and Amicus Therapeutics Inc (FOLD) among others .

Click here to see the complete history of Hayden Donald J Jr’s form 4 insider trades.

Insider Ownership Summary of Hayden Donald J Jr

Ticker Comapny Transaction Date Type of Owner
RGNX Regenxbio Inc 2020-02-10 director
INSM Insmed Inc 2019-04-09 director
FOLD Amicus Therapeutics Inc 2018-01-02 director
LIMIT LIMIT 2016-10-25 director
LIMIT LIMIT 2003-09-10 EVP and President & Americas
LIMIT LIMIT 2022-12-30 director

Hayden Donald J Jr Latest Holdings Summary

Hayden Donald J Jr currently owns a total of 5 stocks. Among these stocks, Hayden Donald J Jr owns 62,197 shares of Insmed Inc (INSM) as of April 9, 2019, with a value of $4 Million and a weighting of 97.72%. Hayden Donald J Jr owns 5,814 shares of Amicus Therapeutics Inc (FOLD) as of January 2, 2018, with a value of $60,989 and a weighting of 1.37%. Hayden Donald J Jr also owns 10,000 shares of Theseus Pharmaceuticals Inc (THRX) as of December 30, 2022, with a value of $40,600 and a weighting of 0.91%. The other 2 stocks Regenxbio Inc (RGNX) , Vitae Pharmaceuticals Inc (VTAE) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Hayden Donald J Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INSM Insmed Inc 2019-04-09 62,197 70.12 4,361,254
FOLD Amicus Therapeutics Inc 2018-01-02 5,814 10.49 60,989
THRX Theseus Pharmaceuticals Inc 2022-12-30 10,000 4.06 40,600
RGNX Regenxbio Inc 2020-02-10 0 10.49 0
VTAE Vitae Pharmaceuticals Inc 2016-03-21 0 21.00 0

Holding Weightings of Hayden Donald J Jr


Hayden Donald J Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 0 transactions in Insmed Inc (INSM) over the past 5 years. The most-recent trade in Insmed Inc is the sale of 6,286 shares on April 9, 2019, which brought Hayden Donald J Jr around $207,375.

According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 20,000 shares on January 2, 2018, which brought Hayden Donald J Jr around $300,000.

According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 1 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 10,000 shares on December 30, 2022, which cost Hayden Donald J Jr around $50,000.

More details on Hayden Donald J Jr's insider transactions can be found in the Insider Trading History of Hayden Donald J Jr table.

Insider Trading History of Hayden Donald J Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hayden Donald J Jr Trading Performance

GuruFocus tracks the stock performance after each of Hayden Donald J Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hayden Donald J Jr is 55.02%. GuruFocus also compares Hayden Donald J Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hayden Donald J Jr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hayden Donald J Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hayden Donald J Jr

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 153.21 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 148.57 LIMIT LIMIT LIMIT LIMIT LIMIT

Hayden Donald J Jr Ownership Network

Ownership Network List of Hayden Donald J Jr

No Data

Ownership Network Relation of Hayden Donald J Jr

Insider Network Chart

Hayden Donald J Jr Owned Company Details

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Hayden Donald J Jr is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Hayden Donald J Jr made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .

In summary, during the past 3 months, insiders sold 20,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenxbio Inc Insider Transactions

No Available Data

Hayden Donald J Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Hayden Donald J Jr. You might contact Hayden Donald J Jr via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.